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Abstract  
p75 neurotrophin receptor (p75NTR) belongs to the TNF-receptor superfamily 
and signals apoptosis in many cell settings. In human epidermis, p75NTR is 
mostly confined to the transit amplifying (TA) subpopulation of basal 
keratinocytes. Brain-derived neurotrophic factor (BDNF) or neurotrophin-4 
(NT-4), that signal through p75NTR, induce keratinocyte apoptosis, while β-
amyloid, a ligand for p75NTR, triggers caspase-3 activation to a greater extent 
in p75NTR transfected cells. Moreover, p75NTR co-immunoprecipitates with 
NRAGE, induces the phosphorylation of c-Jun N-terminal kinase (JNK) and 
reduces nuclear factor kappa B (NF-κB) DNA binding activity. p75NTR also 
mediates pro-NGF-induced keratinocyte apoptosis through its co-receptor 
sortilin. Furthermore, BDNF or β-amyloid cause cell death in TA, but not in 
keratinocyte stem cells (KSC) or in p75NTR silenced TA cells. p75NTR is absent 
in lesional psoriatic skin and p75NTR levels are significantly lower in psoriatic 
than in normal TA keratinocytes. The rate of apoptosis in psoriatic TA cells is 
significantly lower than in normal TA cells. BDNF or β-amyloid fail to induced 
apoptosis in psoriatic TA cells, and p75NTR retroviral infection restores BDNF- 
or β-amyloid-induced apoptosis in psoriatic keratinocytes. These results 
demonstrate that p75NTR plays a proapoptotic role in keratinocytes, and is 
involved in the maintenance of epidermal homeostasis. 
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INTRODUCTION  
The neurotrophins (NTs) nerve growth factor (NGF), brain-derived 
neurotrophic factor (BDNF), neurotrophin-3 (NT-3), and neurotrophin-4 (NT-4) 
are a family of secreted growth factors that exert a wide range of functions in 
the development and maintenance of the nervous system (1). The activities of 
NTs are mediated by two structurally unrelated classes of receptors, the 
common neurotrophin receptor p75 (p75NTR) (2), a member of the tumor 
necrosis factor (TNF) receptor superfamily (3), and the Trk family receptors 
tyrosine kinases (4). While p75NTR binds all NTs with equal low affinity, TrkA 
preferentially interacts with NGF, TrkB with BDNF and NT-4, and TrkC with NT-
3 (2). Trk receptor signaling and activities have been well characterized, and it 
is now widely accepted that the primary role of Trk is the control of neuronal 
survival and differentiation (5). In contrast, the precise role of p75NTR has 
been slow to emerge. Recent findings suggest that p75NTR contributes to 
different signaling pathways. First, p75NTR is a positive modulator of Trk-
mediated functions, in that it acts as a co-receptor that refines Trk affinity and 
specificity for NT (3). On the other hand, p75NTR also controls Trk-independent 
activities. Numerous studies have demonstrated a pro-apoptotic role of 
p75NTR in the nervous system. Indeed, the p75NTR cytoplasmic tail contains 
several potential motifs for interactions with downstream signaling and, similar 
to other members of the TNF receptor superfamily, it comprises the so-called 
“death domain” (6). p75NTR can cooperate with many different protein 
partners and form multimeric receptor complexes to produce a number of 
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cellular responses, including apoptosis (7). p75NTR signaling involves 
modulation of nuclear factor kappa B (NF-κB) and the phosphorylation of c-Jun 
N-terminal kinase (JNK), as well as increased production of ceramides (8). 
Moreover, the precursor form of NTs proNGF binds p75NTR, but not TrkA and 
is a potent inducer of p75NTR-dependent apoptosis. Sortilin, a 95kDa member 
of the Vps10p domain receptors acts as a co-receptor for p75NTR by binding 
the pro region of NGF (9). 
   Human epidermis is a multilayered epithelium where the principal cell type is 
the keratinocyte. Proliferation takes place in the basal epidermal layer and 
differentiation begins as keratinocytes migrate through the suprabasal layers. 
Keratinocyte stem cells (KSC) reside in the basal layer, govern the renewal of 
epidermis, and generate transit amplifying (TA) cells that terminally 
differentiate after a number of cell divisions (10). Human basal keratinocytes 
synthesize and secrete biologically active NGF, NT-3, BDNF and NT-4, and 
express NT receptors (11,12). K252a, an inhibitor of Trk phosphorylation, 
induces apoptosis in human keratinocytes, indicating that autocrine NGF 
protects these cells from programmed cell death through its high affinity 
receptor (13). On the other hand, the role of p75NTR in human keratinocytes 
remains to be elucidated. Considering that the balance between Trk and 
p75NTR seems to be crucial for cell survival or death (14), we wanted to 
investigate the role of p75NTR in human keratinocytes that express both NT 
receptors and undergo apoptosis upon various stimuli, including the inhibition 
of Trk (13).  
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  Hyperproliferation and a distorted differentiation process represent the most 
prominent features of psoriasis.  Psoriasis is an immuno-inflammatory skin 
disease mediated by the release of Th1 and Th17 T cytokines, which in turn 
trigger the keratinocyte response (15). However, keratinocytes could carry 
themselves a defect leading to psoriasis formation (16). In this regard, 
apoptosis is consistently reduced in psoriasis (17), and psoriatic keratinocytes 
are abnormally resistant to apoptosis (18). If p75NTR played a proapoptotic 
role in keratinocyte, we hypothesized that it is also involved in the altered 
epidermal homeostasis typical of psoriasis. 
   We present evidence that p75NTR is predominantly expressed in TA cells and 
induces apoptosis in normal human keratinocytes either alone or in association 
with sortilin. We also show that, even in the presence of Trk, p75NTR can 
mediate apoptosis, thus overcoming Trk survival signals. Furthermore, we 
demonstrate that expression of p75NTR is almost absent in psoriatic lesions.  
β-amyloid or BDNF induce apoptosis in normal, but not in psoriatic TA cells. 
Finally, p75NTR infection restores susceptibility to apoptosis in psoriatic 
keratinocytes.  
 
 
Results  
p75NTR mediates apoptosis in human keratinocytes.  While the presence 
of p75NTR mRNA in human keratinocytes has been previously reported, 
(11,19) its function has never been elucidated. Given the pro-apoptotic activity 
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of p75NTR in most cell systems, we investigated whether p75NTR could 
mediate cell death also in human keratinocytes. To this purpose, and in order 
to overcome binding to Trk, we needed a specific ligand for p75NTR, which 
could trigger Trk-independent functions. β-amyloid specifically binds p75NTR 
with an affinity close to that for NT and mediates apoptosis in neurons and 3T3 
cells (20). When β-amyloid was provided to human keratinocytes, survival was 
significantly affected, as compared to control (Figure 1a). In addition, β-
amyloid-induced apoptosis was significantly higher than control, as shown by 
flow cytometry (subG1 peak, Figure 1b). Caspase-3 is the executioner caspase 
responsible for the final step of the apoptotic machinery and its activation is a 
clear marker of cell death. To confirm p75NTR-mediated apoptosis in human 
keratinocytes, we evaluated the expression of p75NTR and active caspase-3 
after addition of β-amyloid. β-amyloid, but not diluent alone induced the 
activation of caspase-3 in p75NTR positive cells only. In particular, while few 
p75NTR positive cells are caspase-3 negative, all caspase-3 positive cells 
express p75NTR (Figure 1c). We have shown previously that human 
keratinocytes express only the extracellular fragment of TrkB, thus lacking the 
functional high-affinity signaling domain for BDNF and NT-4 (12). Therefore, 
we reasoned that BDNF and NT-4 must perform their activities through 
p75NTR. Indeed, both BDNF and NT-4 significantly induced apoptosis in human 
keratinocytes, in a time-dependent manner, as shown by TUNEL staining 
(Figure 1d). Moreover, the addition of anti-p75NTR neutralizing antibody 
prevented BDNF-induced cell death (Figure 1e). To definitely confirm the pro-
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apoptotic role of p75NTR, we present evidence that both BDNF and β-amyloid 
activated caspase-3 to a greater extent in keratinocytes infected with p75NTR 
retroviral vector, as compared to mock keratinocytes (Figure 1f, g).  
 
p75NTR signals apoptosis in human keratinocytes Several p75NTR 
interacting proteins have recently been identified. In particular, NRAGE has 
been shown to colocalize with p75NTR under physiological conditions and to 
play a role in p75NTR mediated cell death (21). We demonstrated that, in β-
amyloid treated human keratinocytes, p75NTR and NRAGE immunoprecipitates 
are more abundant than in keratinocytes treated with diluent alone (Figure 
2a).  Although, the signal transduction involved in p75NTR-mediated apoptosis 
is still to be completely defined, the critical role of JNK phosphorylation is 
widely accepted (22). We showed that in human keratinocytes, BDNF induced 
the phosphorylation of only JNK1 (Figure 2b), that, unlike JNK2, is essential for 
apoptosis induced by death receptors (23). On the other hand, the role of NF-
κB in p75NTR signal transduction is still controversial. Here, we demonstrate 
that BDNF reduced the DNA binding activity of NF−κB. Reduction was more 
pronounced in p75NTR infected keratinocytes (Figure 2c). This suggests that in 
human keratinocytes, p75NTR exerts its proapoptotic activity also via the 
inhibition of NF-κB. 
 
p75NTR mediates apoptosis in TA cells While p75NTR-induced apoptosis 
was statistically significant, the low percentage of cells undergoing death 
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remained to be explained. To better clarify this issue, we investigated the 
expression of p75NTR in human epidermis. We observed that only a 
subpopulation of basal keratinocytes expressed p75NTR, whereas no p75NTR 
expression was detected in suprabasal layers, as ruled out by the simultaneous 
staining with keratin 10 and transglutaminase I (Figure 3a). To better 
determine the subpopulation of basal keratinocytes expressing p75NTR, we 
isolated and characterized KSC and TA cells, as shown previously (24). p75NTR 
mRNA was significantly more expressed in TA cells than in KSC (Figure 3b). 
Moreover, p75NTR protein was strongly expressed in TA cells and nearly 
absent in KSC, while it was not detectable in postmitotic (PM) cells (Figure 3c). 
If p75NTR is predominantly expressed in TA cells, we predicted that apoptosis 
would occur only in these cells. Indeed, both BDNF and β-amyloid induced 
apoptosis in TA cells, whereas they fail to cause cell death in KSC, as shown by 
the percentage of cells in subG1 peak by flow cytometry (Figure 3d). To 
confirm that p75NTR is responsible for apoptosis in TA cells, we silenced 
p75NTR (Figure 3e), and demonstrated that either BDNF or β-amyloid were not 
able to induce apoptosis in p75NTR siRNA treated TA cells (Figure 3f). It is 
interesting to note that, upon treatment with β-amyloid, the percentage of 
apoptosis was strikingly higher in TA cells than in the whole keratinocyte 
population (Figure 1b), as shown by subG1 peak.  
 
p75NTR mediates pro-NGF-induced keratinocyte apoptosis through its 
co-receptor sortilin Because sortilin acts as a co-receptor for p75NTR and 
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mediates apoptosis in other cell settings (9), we first evaluated sortilin 
expression in human keratinocytes. These cells contained levels of sortilin 
mRNA which were almost three fold the amount of p75NTR (Figure 4a). 
Similarly, flow cytometry demonstrated that sortilin protein was expressed in a 
significantly higher number of cells than p75NTR (Figure 4b), consistent with 
the wide variety of functions of this protein. As p75NTR was predominantly 
expressed in TA cells, we examined the pattern of sortilin expression in the 
same subpopulation of keratinocytes. Consistently with p75NTR, sortilin was 
expressed mostly in TA cells, while KSC contained a slightly higher amount of 
sortilin than PM cells, both at the mRNA and at the protein level (Figures 4c 
and d). It has been proposed that proNGF binds p75NTR, whereas mature NT 
binds TrkA. Inhibiting sortilin in cells that normally express p75NTR, 
suppresses proNGF-mediated cell death (9). As sortilin and p75NTR were both 
predominantly expressed in TA cells, we wanted to evaluate the effect of pro-
NGF in keratinocytes. Increasing doses of proNGF reduced keratinocyte 
viability (Figure 4e). Moreover, co-addition of proNGF and the Trk inhibitor 
k252a decreased the rate of cell survival to a greater extent as compared to 
proNGF or k252a alone (Figure 4f), indicating that simultaneous blockade of 
Trk signaling and binding of p75NTR is a strong proapoptotic stimulus. This 
was further confirmed by the TUNEL method, which demonstrated a significant 
rate of apoptosis induced by proNGF, which was significantly augmented by the 
addition of k252a (Figure 4g). To definitely confirm the proapoptotic role of 
p75NTR, we transfected HaCaT keratinocytes with a combination of pcDNA3-
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p75NTR and pcDNA3-sortilin (Figure 4h). While transfection alone failed to 
exert any proapoptotic effect, the addition of proNGF significantly promoted 
apoptosis to the same level as the positive control (Figure 4i). Taken together, 
these results indicate that p75NTR together with sortilin mediates the 
proapoptotic role of proNGF in human keratinocytes, even in the presence of 
Trk. 
 
p75NTR is reduced in lesional psoriatic epidermis We had previously 
shown that psoriatic lesions express higher levels of NGF as compared to 
normal skin (25), which accounts for the increased sprouting of p75NTR and 
TrkA positive terminal cutaneous nerves (26). In the present study, we focused 
on the expression of p75NTR and Trk receptors in psoriatic keratinocytes. By 
immunohistochemistry, p75NTR was detected occasionally in few basal cells 
from non lesional psoriatic skin, expression being substantially reduced as 
compared to normal skin. Interestingly, p75NTR protein was completely absent 
in lesional psoriasis (Figure 5a). To better understand this finding, we 
evaluated p75NTR expression at the mRNA level. Both Northern Blot (Figure 
5b) and Real Time PCR (Figure 5c) revealed that p75NTR mRNA was normally 
expressed in psoriatic epidermis. Yet, Western blotting on protein lysates from 
epidermis (Figure 5d) and flow cytometry (Figure 5e) on suspended cells 
confirmed the lack of p75NTR protein in psoriatic keratinocytes. On the other 
hand, TrkA protein levels were higher in non lesional and lesional psoriatic 
epidermis than in normal epidermis. While TrkB was slightly decreased in 
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psoriatic skin, TrkC remained unchanged. Finally, sortilin was slightly increased 
in lesional psoriatic epidermis (Figure 5d). 
 
 
Defective p75NTR renders psoriatic TA cells resistant to apoptosis  
  
Because TA cells express the highest levels of p75NTR, we compared its 
expression in TA cells in normal and psoriatic keratinocytes by flow cytometry. 
While no major variations were detected in KSC and PM cells between normal 
and psoriatic keratinocytes, TA cells from psoriatic keratinocytes presented a 
four-fold decrease in p75NTR expression as compared to TA from normal cells 
(Figure 6a). Because TA cells are more prone to cell death than KSC (24) and 
reduced expression of p75NTR in TA cells seems to account for the low levels 
of p75NTR in psoriasis, we compared the rate of apoptosis in TA and KSC from 
normal and psoriatic skin. While percentage of apoptotic cells was similar in 
KSC from healthy and diseased skin, TA cells from psoriatic skin were 
statistically less susceptible to apoptosis than the same cells from normal skin, 
as shown by propidium iodide staining in situ (Figure 6b). As β-amyloid and 
BDNF induce apoptosis in normal keratinocytes, we analyzed their effect on TA 
cells from psoriatic and normal keratinocytes. While β-amyloid or BDNF 
significantly reduced viability and induced apoptosis (subG1 peak) in TA cells 
from normal epidermis, they failed to exert any effect on TA cells from 
psoriatic keratinocytes (Figure 6c, d). 
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Overexpression of p75NTR restores apoptosis in psoriatic 
keratinocytes 
 
Because psoriatic epidermis is characterized by defective apoptosis (17) and 
reduced p75NTR, we wanted to investigate the function of this receptor in 
psoriatic keratinocytes. To this purpose, we infected psoriatic keratinocytes 
with p75NTR retroviral vector (Figure 7a) and treated cells with either β-
amyloid or BDNF. Both stimuli reduced viability in p75NTR infected psoriatic 
keratinocytes, but not in mock psoriatic cells (Figure 7b). 20% difference in 
viability roughly corresponds to the percentage of p75NTR infected cells (data 
not shown). Moreover, while infection with p75NTR increased the rate of 
apoptosis in untreated cells (cntrl), BDNF induced a significantly higher 
percentage of cells in subG1 peak in p75NTR infected, as compared to either 
mock keratinocytes or to infected keratinocytes treated with diluent alone 
(Figure 7c).  
 
 
 
Discussion 
NTs and their receptors are expressed in most human skin cells, constituting a 
network potentially responsible for multiple functions (12, 27).  In this context, 
we detected p75NTR in basal keratinocytes, in agreement with previous 
reports. While those were mostly incidental observations in studies related to 
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p75NTR expression in cutaneous nerve fibers or during skin pathologies (28), 
our work precisely addresses p75NTR localization in human epidermis. We 
detected p75NTR in basal, but not in suprabasal keratinocytes, as confirmed by 
the double staining with keratin 10 and transglutaminase I. This is in general 
agreement with p75NTR expression in other multilayered epithelial cells, 
including prostate and esophagus. On the other hand, while in other epithelia 
p75NTR appears to be evenly distributed, the localization pattern in human 
epidermis seems to be unique, in that only a subpopulation of the germinative 
basal layer expresses the receptor. We present evidence that p75NTR is almost 
exclusively expressed in TA cells, with little protein observed in KSC. Although 
several markers have been proposed, KSC and TA cells are still difficult to be 
clearly defined. TA cells have been shown to be more susceptible than KSC to 
apoptosis (29). In fact, TA cells express higher levels of proapoptotic and lower 
levels of antiapoptotic markers, as opposed to KSC (24). Our finding of p75NTR 
being predominantly expressed in TA cells seems to be consistent with the pro-
apoptotic role of this receptor in human keratinocytes. Keratinocytes also 
express Trk receptors (11, 12), and NTs activities strongly depend on the 
relative expression of the two receptors on the target cell population (30). 
When both receptors are expressed, NTs bind to Trk-p75NTR high-affinity 
complex and mediate survival signals in many cell settings (2). In this study, 
using specific ligands for p75NTR, we were able to induce apoptosis, thus 
counteracting the survival effects mediated by Trk. Indeed, β-amyloid 
specifically binds p75NTR and induces apoptosis only in keratinocytes 
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expressing p75NTR, similarly to β-amyloid peptide-induced cell death in 
Alzheimer’s neuronal cells (31) and in neuroblastoma (32). Because β-amyloid 
is not a physiologic ligand for p75NTR in human epidermis, we treated 
keratinocytes with BDNF or NT-4 that bind p75NTR, in absence of TrkB. In fact, 
BDNF or NT-4 significantly increase the rate of cell death, and induce a high 
degree of caspase-3 activation in p75NTR overexpressing keratinocytes. The 
signaling pathways underlying the p75NTR-dependent apoptotic response 
involve a number of factors. NRAGE, a p75NTR-interacting protein disrupts 
p75NTR-TrkA complex, and induces cell death through JNK-dependent pathway 
(21), thus contributing to p75NTR-dependent apoptosis. Consistent with these 
findings, we provide evidence that upon binding with a specific ligand, p75NTR 
interacts with NRAGE and phosphorylates JNK in human keratinocytes. While 
JNK activation was mostly demonstrated by overexpressing p75NTR or after 
serum withdrawal in the nervous system, the present study indicates that 
BDNF, released at the skin level, signals apoptosis, by phosphorylating JNK. 
p75NTR also activates NF-κB, which is mainly viewed as an anti-apoptotic 
signalling factor. On the other hand, in neonatal rat oligodendrocytes, 
activation of NF-κB was shown to be associated with apoptosis. Our findings 
indicate that in human keratinocytes, p75NTR signals apoptosis via the 
reduction of NF-κB anti-apoptotic function. Taken together, these results 
suggest that p75NTR has its own signaling pathway also in human 
keratinocytes. 
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   In the neuronal system, proNGF binds to p75NTR and its co-receptor sortilin, 
but not to Trk, whereas mature NTs bind to Trk only, leading to the conclusion 
that the precursors and the mature NTs elicit opposing responses, that is cell 
death and survival, respectively (9, 33). Here we show that human 
keratinocytes express sortilin with a pattern similar to that of p75NTR. Indeed, 
sortilin is predominantly expressed in TA cells, which are more prone to 
apoptosis (24). This study also shows that proNGF induces keratinocyte 
apoptosis, while the simultaneous inhibition of Trk phosphorylation by k252a 
elicits an additive proapoptotic activity, further indicating that the two NT 
receptors exert opposing effects also in keratinocytes (13). While co-
transfection of p75NTR and sortilin per se failed to induce apoptosis, addition 
of proNGF to transfected cells significantly stimulated caspase activation, 
consistent with the concept that also in keratinocytes, proNGF acts as a 
crosslinker, creating a ternary complex with sortilin and p75NTR (9). In 
substance, we have shown that p75NTR acts as a proapoptotic receptor in 
human keratinocytes either when it is ligated by proNGF or by mature NTs. 
This latter mechanism is at variance with the view that, in the presence of Trk, 
p75NTR is a facilitator of Trk-mediated survival in the nervous system. A 
possible explanation relies on the following observations: 1. While in the 
neuronal system, high concentrations of mature NTs required to induce even 
modest levels of apoptosis are considered non-physiological (34), in human 
epidermis, the NT-4, BDNF or other yet unidentified ligands could autocrinally 
and paracrinally be continuously released and in turn bind p75NTR, thus 
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overcoming Trk functions. 2. Epithelial cells behave differently from neurons, 
as normal prostate and bladder cells express Trk (35, 36) and still undergo 
apoptosis via p75NTR binding (37). It has been recently shown that, under 
certain circumstances and stimuli, a Trk-to-p75NTR molecular switch occurs 
favoring cell death (38). 
   p75NTR is nearly absent in psoriatic keratinocytes that are reportedly 
resistant to apoptosis.  On the other hand, restoring p75NTR levels renders 
psoriatic keratinocytes again susceptible to cell death. This indicates that 
p75NTR plays a role in epidermal homeostasis and its deficiency accounts for 
the well-documented resistance of psoriatic keratinocytes to apoptosis. 
Moreover, p75NTR alteration, coupled with the marked overexpression of NGF 
and TrkA that mediate survival signals, indicates that the imbalance of NGF 
receptors underlies the disturbed epidermal homeostasis in psoriasis.  Early 
mathematical models describing cell renewal in psoriasis had demonstrated 
that the typical psoriatic tissue architecture is based not only on an increased 
turnover rate in the germinative cell, but also on a defect in cells transiting to 
the more differentiated state. More recently, Castelijins and co-workers, using 
kinetics parameters, have proposed that epidermal abnormalities in psoriasis 
are due to a defect in the transit-amplifying compartment, rather than to a 
reduction in the cell cycle time. TA cells in psoriasis are thought to be kept in a 
prolonged proliferative state, which would account for an increased number of 
cell division, with no reduction of cell cycle time (39). Alternatively, the defect 
in TA could be due to a lack of differentiation/apoptosis. This has been recently 
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confirmed by in-silico studies simulating psoriasis by altering TA cells (40). The 
inherent malfunction in the behavior of this subpopulation is enforced by 
altered levels of a number of markers in TA from psoriatic lesions as compared 
to TA from normal skin (41). The present work demonstrates that the most 
remarkable reduction in p75NTR expression was detected in TA cells. This 
finding, together with the lesser susceptibility to apoptosis of psoriatic TA cells, 
strongly indicates that alteration of TA cells in psoriasis is partly based on a 
defect in p75NTR. While there seems to be a general agreement on the 
prominent role of TA cells in psoriasis, those works were mostly based on 
computational and expression data. Here we show that stimuli that induce 
apoptosis through p75NTR in TA cells from normal epidermis, fail to do so in 
psoriatic TA, providing the first functional insight into the defect of this 
keratinocyte subpopulation in the pathogenesis of psoriasis. If p75NTR mRNA 
is normally expressed in psoriatic keratinocytes, there must be some post-
translational alteration leading to the disappearance of the protein, possibly 
related to a calcium defect in psoriatic keratinocytes (42). In conclusion, 
p75NTR acts as a proapoptotic receptor in human keratinocytes and plays a 
crucial role in epidermal homeostasis.  
 
Materials and methods 
Cell Culture 
Normal human keratinocytes were obtained from foreskin and cultured in 
serum-free medium KGM (Clonetics, San Diego, CA) as described (12). Freshly 
 18 
keratinocytes were also divided into three populations and plated onto plastic 
dishes, coated for 2 hours at 37°C with type IV collagen 100µg/ml (Sigma, St. 
Louis, MO).  They were first allowed to adhere to type IV collagen for 5 min, 
and the non-adherent cells were then transferred to fresh collagen-coated 
dishes and allowed to attach overnight. Finally, keratinocytes not yet attached 
after one night were plated onto type IV collagen to obtain a third population. 
The three keratinocyte populations were characterized based on β1-integrin 
levels and colony forming efficiency, as previously described (24). This allowed 
to obtain a population enriched in KSC, a population consisting of TA cells and 
a third population of PM cells. Keratinocytes were then cultured in serum-free 
medium (KGM) and used for further experiments. The spontaneously 
transformed keratinocyte line HaCaT was kindly provided by Dr. N. Fusenig 
(DKFZ Heidelberg). 
 
Western blotting analysis 
Cells or epidermis coming from skin biopsies were washed with phosphate-
buffered saline (PBS) and lyzed on ice, for Trk, sortilin and JNK detection, in 
lysis buffer pH 7.4 (50mM Tris-Hcl, 1% NP40, 0.25% sodium deoxycholate, 
150mM NaCl, 1 mM EGTA, 1mM Na3VO4, 1mM NaF), for p75NTR detection in 
lysis buffer pH 7.5 (150mM NaCl, 15mM MgCl, 1mM EGTA, 50mM Hepes, 10% 
Glicerolo, 1% Triton) or, for caspase-3, with lysis buffer pH 6.8 (62.5mM Tris-
HCl, 2% SDS, 10% glycerol, 50mM DTT, 0,01% bromophenol blue) containing 
protease inhibitors, as described previously (12). 20µg of total protein were 
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analyzed under reducing conditions for sortilin and JNK on 7% polyacrylamide 
gels and blotted onto nitrocellulose membranes. To verify equal loading of total 
proteins in all lanes, the membranes were stained with Ponceau Red. The blots 
were blocked for 2 hours in blocking buffer (PBS buffer, pH 7.4, with 0.2% 
Tween 20 and 5% nonfat milk) and incubated overnight at 4°C with anti-
p75NTR mouse monoclonal (1:1000; Upstate, Lake Placid, NY, USA), anti-TrkA 
rabbit polyclonal (1:1000; Upstate), anti-TrkB rabbit polyclonal (1:750; 
Upstate), anti-TrkC goat polyclonal (1:750; Upstate), anti-sortilin mouse 
monoclonal antibody (1:250, BD Biosciences Pharmingen, San Diego, CA, 
USA), anti-active JNK (1:5000, Promega, Madison, WI, USA), anti-caspase-3 
(1:1000, Cell Signaling Technology, Boston, MA, USA) or with anti-β-actin 
mouse monoclonal antibody (1:5000; Sigma) as a control. Then membranes 
were washed in PBS/Tween 20, incubated with peroxidase-conjugated goat 
anti-rabbit antibody, anti-mouse antibody (1:3000; Biorad, Hercules, CA, USA) 
or donkey anti-goat antibody (1:1000; Santa Cruz Biotechonology Inc, Santa 
Cruz, CA, USA) for 45 min at room temperature, washed, and developed using 
the ECL chemiluminescent detection system (Amersham Biosciences UK 
Limited, Little Chalfont Buckinghamshire, England).  
 
Immunoprecipitation 
Human keratinocytes were treated with or without 40 µM β-amyloid. 24h later 
cells were harvested with RIPA buffer (10mM Tris, pH 8.0; 150mM NaCl; 1% 
Nonidet P-40, 0.5% deoxycholate; 0,1% SDS) containing protease inhibitors. 
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Nuclei were removed by centrifugation (11,000rpm for 3 min). Monoclonal 
antibody anti-p75NTR (Upstate) or polyclonal serum against NRAGE (kindly 
provided from professor P.A. Barker) were bound to sepharose beads 1h at 
4°C under rotation. Then, pre-cleared lysates were coniugated to sepharose 
beads-antibody complex or to sapharose beads alone as control, overnight at 
4°C under rotation. Immunocomplexes were washed with Port Buffer (10mM 
Tris-HCl, pH 8.5; 150mM NaCl; 0.1% Renex 30; 0.01% BSA; 2.5% NaN3) six 
times and with PT Buffer (10mM Tris-HCl, pH 8.5; 150mM NaCl; 0.5% Tween 
20; 2.5% NaN3) three times. Samples were eluted with 1X Laemnli sample 
buffer for 5°C at 90°C and Western Blotting for p75NTR or NRAGE was 
performed as previously described.   
 
Transfection of HaCaT cells 
For p75NTR and sortilin transient transfection, cells were seeded in 6-well 
plates (5x105 cells/well) and in 96-well tissue culture plate (4x104 cells/well) in 
antibiotic-free medium. HaCaT cells were double transfected using 
Lipofectamine Plus reagent  (Invitrogen Corporation, Carlsbad, CA, USA) with 2 
µg/well (in 6-well plates) or 0.15µg/well (in 96-well plates) of pcDNA3-BimEL 
or pcDNA3-p75NTR or pcDNA3-sortilin overnight in Opti-MEM medium 
(Invitrogen Corporation). Then cells were treated with various stimuli for 
further experiments and p75NTR or sortilin protein level was detected by 
Western blotting, as described below. 
 
 21 
siRNA transfection of TA cells 
About 7x104 TA cells/well were plated on 6-well plates in 
penicillin/streptomycin free medium. 24 hours later cells were transfected with 
50nM or 100nM p75NTRsiRNA (Dharmacon Inc, Lafayette, CO, USA) or 
scrambled RNAi as mock control, combined with Lipofectamin 2000 and Opti-
MEM (both from Invitrogen Corporation) as datasheet suggests. Cells were 
transfected twice and used for FACS analysis. p75NTR protein level was 
detected by Western blotting, as described below. 
 
Infection of normal and psoriatic keratinocytes 
106 cells from normal or psoriatic biopsies were plated on 75cm2 flask over a 
feeder-layer of mitomycin C trated 3T3 fibroblasts (7x105 cells for 75cm2 flask) 
and mitomycin C trated p75NTR-LNSN packaging cells (3.5x105 for 75 flask) or 
mitomycin C trated LNSN packaging cells (kindly provided from professor F. 
Mavilio) with medium for keratinocytes (11) without EGF. 48 hours later EGF 
was added to the cultures. 24 hours after infection cells were plated in KGM for 
MTT, PI or Western blot analysis. 
 
Real Time PCR 
RNA from cells separated into the three populations or from total keratinocytes 
or from healthy or psoriatic epidermis was extracted using TRI Reagent 
method performed as described by Sigma. To verify the quality of the RNA, we 
ran an agarose minigel in RNase-free conditions. Quantitative Real Time PCR 
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was performed with an ABI 7500 (Applied Biosystems, Foster City, CA, USA) 
for p75NTR and sortilin. As an internal control, housekeeping gene β-actin 
mRNA expression was measured in a separated tube. H2O RNAse-free was 
used as a negative control. We performed three independent experiments, and 
each one was analysed in a triplicate PCR-reaction. Then, 1µg of RNA was 
subjected to retro-transcription and amplification in a 50µl reaction mixture 
using the One-Step RT-PCR Master Mix Reagents kit (Applied Biosystems). For 
p75NTR, sortilin and β-actin were used Pre-Developed TaqMan Assay Reagents 
(MGB™ probes were FAM or VIC dye labelled, Applied Biosystems). Thermal 
cycling conditions for One-Step RT-PCR were: initial reverse transcription at 
48°C for 30 min, then DNA Polymerase activation at 95°C for 10 min, followed 
by 40 cycles of denaturation at 95°C for 15 s, annealing/extension at 60°C for 
1 min.  Data from each sample were compared with a calibrator, using the 
Sequence Detection Software Version 1.2.3 according to the Relative 
Quantification Study method (Applied Biosystems).  Results were obtained as 
the mean from three independent experiments. Double-sided Student’s t-test 
was performed between samples and calibrator. 
 
Immunohistochemistry 
For double staining, cryosections (4µm) of normal human skin were acetone-
fixed, rehydrated in phosphate-buffered saline (PBS). Quenching of the 
endogenous peroxidase activity was obtained by treatment with 3% H2O2 in 
PBS. Samples were incubated either with mouse anti-transglutaminase type I 
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(1:10, Biomedical Technologies Inc, Stoughton, MA, USA) or with mouse anti-
cytokeratin 10 antibody (1:50, Dako, Glostrup, Denmark) for 1 hour, then with 
secondary antibody anti-mouse biotinylated (1:3000, Dako) for 45 min and 
with a streptavidin-biotin peroxidase complex for 30 min. The reaction 
products were visualized with amino-methylene-carbazole. Double staining was 
continued incubating the slides with 1% goat serum. Then the slides were 
incubated with mouse anti-p75NTR antibody (1:250, Lab Vision Corporation, 
Neomarkers, Fremont, CA, USA) for 1 hour and, after three washes of 5 min in 
PBS, slides were incubated with secondary antibody anti-mouse (1:20, Dako) 
for 45 min at room temperature, followed by incubation with anti-mouse 
alkaline phosphatase complex for 30 min (1:20, Dako). After three washes of 5 
min in PBS, the slides were stained with Fast blue (Sigma). Negative controls 
were obtained by omitting primary antibody. 
For single staining, cryosections (4µm) of normal, non lesional and lesional 
psoriatic human skin were acetone-fixed (10 min), rehydrated in phosphate-
buffered saline (PBS). The slides were incubated with mouse anti-p75NTR 
antibody (1:250, Lab Vision Corporation) for 1 hour and, after three washes of 
5 min in PBS, incubated with secondary antibody anti-mouse (1:20, Dako) for 
45 min at room temperature, followed by incubation with anti-mouse alkaline 
phosphatase complex for 30 min (1:20, Dako). After three washes of 5 min in 
PBS, the slides were stained with New fucsin (Sigma). 
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Confocal immunofluorescence 
For double staining, keratinocyte cultures were washed in PBS buffer and fixed 
in situ in 4% paraformaldehyde for 20 min and air dried.  After a rehydratation 
in PBS, cells were permeabilized for 10 min with 0.5% Tryton X-100 in 0.1% 
sodium citrate, treated for 5 min with 50 mM NH4Cl and incubated with 1% 
bovine albumin serum for 20 min. Then cells were incubated for 1 hour with 
the mouse monoclonal anti-caspase-3 active antibody (1:100, R & D Systems, 
Minneapolis, MN, USA) and for 1 hour with RPE Cy5-conjugated anti-mouse 
(dilution 1:100, Dako). Then keratinocytes were washed in PBS, labelled with a 
mouse anti-p75NTR antibody (1:250, Lab Vision Corporation) for 1 hour and 
with FITC-conjugated anti-mouse antibody (dilution 1:100, Dako) for 45 min. 
Fluorescent specimens were analyzed by a Confocal Scanning Laser Microscopy 
(Leica TCS SP2).  
 
MTT assay 
Keratinocytes or transfected HaCaT were plated in 96-well tissue culture plate 
(8000 cells/well). 72 hours after seeding, cells were treated with 40µM β-
amyloid (25-35) (Bachem, Bubendorf, Switzerland) or 100ng/ml BDNF or 
100ng/ml NT-4 or different doses of proNGF (kindly provided from B. 
Hempstead) for 24, 48 and 72 hours. Proliferative cells were detected by 
incubating with MTT (Sigma-Aldrich) solution at 37°C for 4 hours. They were 
solubilizated with DMSO and the formazan dye formation was evaluated by 
scanning multiwell spectrophotometer at 540 nm. The results are expressed as 
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optical density units (OD) or as viability percentage respect of control. Results 
are calculated as the mean ± SD of three different experiments. Student’s T-
test was used for comparison of the means. 
 
Cell death analysis by Flow cytometry 
72 hours after seeding, cells were treated with 40µM β-amyloid or 100ng/ml 
BDNF. 24 or 48 hours later, cells were trypsinized and resuspended (5x105 
cells) in 1ml hypotonic fluorochrome solution: 50µg/ml propidium iodide 
containing 0.1% sodium citrate and 0.5% Tryton X-100 (Sigma). After 15 min, 
cells were analyzed using an Epics XL flow cytometer (Coulter Electronics Inc., 
Hialeah, FL, USA). Apoptosis was detected by evaluating the reduced 
fluorescence of the DNA binding dye PI in the apoptotic nuclei. 
 
TUNEL assay 
Cells after treatment were fixed in situ in paraformaldehyde (4% in PBS) and 
air dried. The slides were stained with the “In situ cell death detection kit” 
(Roche Diagnostics, Basel, Switzerland) as recomended by the manufacturer. 
Fluorescent specimens were analyzed by Confocal Scanning Laser Microscopy 
(Leica TCS SP2) in conjunction with a conventional optical microscope (Leica 
DM IRBE). Results are calculated as the mean ± SD of three different 
experiments. Student’s T-test was used for comparison of the means. 
 26 
 
Detection of apoptotic cells by confocal microscopy 
Cell were seeded on glass coverslips coated with poly-L-lysine 100mg/ml for 5 
min, fixed in methanol:water (80:20) for 5 min, washed in phosphate-buffered 
saline (PBS) and subsequently stained with propidium iodide (Sigma, 5µg/ml in 
PBS) for 5 min. Coverslips and examined by laser-scanning confocal 
microscopy (Leica TCS-SP2) to identify apoptotic nuclei. Nuclei were scored 
and more than 400 nuclei were counted for each sample. The results are 
expressed as percentage of the number of apoptotic nuclei over the total 
number of nuclei examined. 
 
FACS analysis 
Keratinocytes were washed in PBS and incubated with mouse biotin-coniugated 
anti-p75NTR (20µl/1x106 cells, BD Biosciences Pharmingen) or rabbit 
polyclonal anti-sortilin antibody (1:2000, kind gift from Claus M. Petersen, 
Aarhus University, Denmark) for 20 min at 4oC. For sortilin, after a brief 
washing in PBS, the cells were incubated with the biotinylated anti-rabbit 
antibody 1:500 (Dako, Glostrup, Denmark) for 20 min on ice. For both 
staining, the incubation with antibodies was followed by incubation with 
streptavidin/RPE-Cy5 1:50 (Dako) for 20 min on ice. After washing, cells were 
analyzed using an Epics XL flow cytometer. 
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Caspase Activity Measurements  
The caspase-3-like protease activity in cell lysates was measured using a 
fluorometric substrate Ac-DEVD-AFC (Alexis Corporation, San Diego, CA, USA), 
which was dissolved in dimethyl sulfoxide and stored as a 10mM solution at -
20°C. HaCaT cells were collected, washed in cold PBS, and lysed at 4°C in 
buffer A (50mM HEPES, pH 7.5, 150mM NaCl, 20mM EDTA, 1 mM 
phenylmethylsulfonyl fluoride, 10µg/ml leupeptin, 1µg/ml aprotinin, and 0.3% 
Nonidet P-40). Homogenates were centrifuged (13,000 rpm, 10min), and the 
protein concentrations of the supernatants were determined using a Bradford 
protein assay kit (Bio-Rad). Equal amounts of supernatants (normalized for 
protein content) were mixed in wells of 96-well plates in a 100µl final volume, 
in buffer B (50mM HEPES, pH 7.4, 100mM NaCl, 1mM EDTA, 10% sucrose, 
0.5% CHAPS, 5mM dithiothreitol, and 100 µM Ac-DEVD-AFC substrate 
(caspase-3/7). Substrate cleavage was monitored continuously by 
spectrofluorometry, in kinetic mode, using Fluorolite 1000 (Dynatech 
Laboratories Inc., Chantilly, VA, USA). Data are reported as relative 
fluorescence units of product produced/min/10µg of total protein. 
 
Northern blot 
Northern Blot was performed using DIG Northern Starter Kit (Roche). Briefly, 
total cellular epidermal mRNA taken from biopsies of patient with or without 
psoriasis was isolated with 1 ml of TRI Reagent performed as described by 
Sigma. p75NTR DNA in pCEP4 vector was linearized at restrinction sites 
 28 
downstream of the cloned insert and purified. PCR of p75NTR vector using T7 
RNA polymerase promoter sequences (FW:5’-CTCATCCCTGTCTATTGCTCCA-
3’;REV:5’-TAATACGACTCACTATAGGAGCTGGAGCATCGGTTGTC-3’) was 
performed using Expand Figh Fidelity PCR System (Roche). 1 µg of p75NTR 
DNA template was labeled with T7 RNA polymerase for 1 hour at 42°C, after 
that DNAse I was added for 15 min at 37°C, to remove DNA template, as 
manufacture’s instructions. Yield of DIG-labeled p75NTR RNA was determined 
comparing it to DIG-labeled actin RNA as control (10ng/µL). 2 µg of total RNA 
from patients was loaded in MOPS/formaldehyde gel. RNA was blotted over 
nylon membrane, positively charged, by capillary transfer over night. The RNA 
was fixed by short-wave UV exposure and RNA hybridization was performed 
using DIG-labeled p75NTR probe at 68°C over night with gentle agitation. 
Membrane was incubated with anti-digoxigenin-AP, Fab fragments (1:10000) 
in blocking solution) 30 min at room temperature. Membrane was washed, 
equilibrated for 5 min and covered with CDP-Star ready-to-use solution for 5 
min at 20°C and signal imaging was developed. To perform actin control, 
membrane was stripped and hybridized with DIG-labeled actin RNA probe and 
detection was performed as described before. 
 
Gel mobility shift assay 
Nuclear proteins were isolated from the cellular pellets. Samples were 
suspended with hypotonic buffer (1.5 mM MgCl2, 0.2 mM PMSF, 1 mM DTT, 10 
mM KCl, 10 mM HEPES, pH 7.9) for 15 min. Proteins were centrifuged, then  
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the pellets were washed with hypotonic buffer and centrifuged. Supernatants 
were discarded and pellets were suspended in low salt buffer (25% glycerol, 
1.5 mM MgCl2, 0.2 mM EDTA, 0.2 mM PMSF, 1 mM DTT, 20 mM KCl, 20 mM 
HEPES, pH 7.9). Nuclear proteins were released by adding high salt buffer 
(25% glycerol, 1.5 mM MgCl2, 0.2 mM EDTA, 0.2 mM PMSF, 1 mM DTT, 1.2 M 
KCl, 20 mM HEPES, pH 7.9). Samples were incubated on ice for 30 min, 
centrifuged and supernatants were collected and stored at -70 °C. 
Double-stranded oligonucleotides for the NF-κB-binding site were obtained 
from Santa Cruz Biotechnology and labeled with [γ-32P] ATP (Perkin-Elmer, 
Waltham, MA, USA) and T4 polynucleotide kinase (Promega). The labeled 
oligonucleotides were separated on a SDS-PAGE gel and eluted out of the gel 
in distilled H2O (4 °C, overnight) and the activity of labeled probe counted. 
Total of 5 µg of nuclear proteins were used in each reaction. Extracts were 
incubated with the radiolabeled probe in binding buffer (4 mM Tris-HCl, 12 mM 
HEPES at pH 7.9, 60 mM KCl, 0.5 mM EDTA, 1 mM dithiothreitol, and 12% 
glycerol) for 25 min at room temperature. Non-specific binding was blocked by 
2 µg of poly(dI-dC):poly(dI-dC) (Sigma). After incubation, samples were 
fractionated on a 4% polyacrylamide gel in 0.25x Tris-borate-EDTA at 4°C. 
Following electrophoresis, the gel was dried and autoradiographed. 
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Legends 
 
Figure 1 p75NTR modulates apoptosis in normal human keratinocytes 
in vitro. (a) Confluent keratinocyte cultures, seeded in a 96-well tissue culture 
plate, were treated with 40µM β-amyloid or diluent alone. MTT was performed 
24 hrs later. Results are expressed as the mean ± SD of three different 
experiments. Student’s T-test was used for comparison of the means. (b) 
Confluent cells were treated as described before, trypsinized at 24 hrs and 
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stained with PI. Cells in subG1 peak were analyzed by flow cytometry. (c) 
Keratinocytes cultures, seeded on chamber slides, were provided with 40µM β-
amyloid or diluent for 24 hrs. Cells were fixed, double stained in situ with anti-
p75NTR and anti-active caspase-3 antibodies, and analyzed by a Confocal 
Scanning Laser Microscopy. (d) Confluent keratinocyte cultures were treated 
with BDNF or NT-4 (100ng/ml). At 24, 48 and 72 hrs cells were fixed and 
stained in situ with TUNEL. Positive cells were counted as described in M&M. 
(e) Confluent keratinocytes were treated individually or in combination with 
100ng/ml BDNF and 50µg/ml mouse anti-p75NTR neutralizing antibody. After 
48 hrs, cells were stained in situ with TUNEL and positive cells were counted as 
described in M&M. (f) Keratinocytes were transiently infected with p75NTR-
LNSN packaging cells or LNSN packaging cells as mock control. Both mock and 
transfected cells were treated with BDNF (100ng/ml) or β-amyloid (40µM). 48 
hrs after treatment, protein extracts from keratinocytes were analyzed by 
Western blotting for p75NTR and caspase-3 expression. β-actin was used as 
internal control.  (h) Relative intensity of bands on radiograms was quantified 
by laser scanner densitometry. Values of pro-caspase-3 and caspase-3 
fragment are expressed as fold variations compared to mock-diluent 
keratinocytes. 
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Figure 2 p75NTR induces apoptosis via JNK and NF-κB (a) Keratinocytes 
were treated for 24h with β-amyloid (40µM) or diluent. Protein extracts were 
immunoprecipitated with NRAGE serum and immunoblotted with p75NTR 
antibody and with NRAGE serum as control. Cell lysates were also 
immunoprecipitated with p75NTR antibody, immunoblotted with NRAGE serum 
and with p75NTR antibody as control. (b) Confluent keratinocytes were treated 
for 5 min with BDNF (100ng/ml) and protein extracts were analyzed by 
Western blotting using anti-active JNK1 polyclonal antibody. PC12 cells treated 
with 0.5M sorbitol for 5 minutes were used as positive control. (c) 
Keratinocytes were infected with p75NTR and treated with with 100ng/ml 
BDNF or diluent alone for 12h. Nuclear protein extracts were analyzed by Gel 
mobility shift assay for NF-κB DNA binding activity. 
 
 39 
 
Figure 3 p75NTR-induced apoptosis in TA cells (a) Cryosections of normal 
skin were acetone-fixed and stained with anti-p75NTR antibody. Fast red was 
used as cromogen for p75NTR. Cryosections were double stained with anti-
p75NTR and anti-keratin 10 (CK10) antibodies or with anti-p75NTR and 
transglutaminase type I (TgaseI) antibodies. Fast blue was used as cromogen 
for p75NTR while carbazol for CK10 and TGaseI. (b) Normal human 
keratinocytes were obtained from neonatal foreskin and separated into three 
subpopulations on type IV collagen. A Real Time PCR was performed on RNA 
extracts of the three populations by using primers for p75NTR, as described in 
M&M. KSC were used as calibrator. Student’s T test was performed between 
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samples and calibrator. (c) Protein extracts from the three populations were 
separated on 7% polyacrylamide gels and transferred onto nitrocellulose 
membrane. Membranes were immunoblotted with anti-p75NTR antibody. β-
actin was used as internal control. (d) KSC and TA cells were treated with 
either BDNF or β-amyloid, stained with P.I., and analyzed by flow cytometry. 
(e) TA cells were transiently transfected with 50nM of p75NTR siRNA, as shown 
by Western blotting. (f) 48 hrs after transfection, both mock and transfected 
cells were treated with BDNF  (100ng/ml) or β-amyloid (40µM). SubG1 peak 
analysis was performed 24 hrs later. 
 
 
Figure 4 ProNGF mediates apoptosis in human keratinocytes through 
p75NTR and sortilin. (a) Normal human keratinocytes were obtained from 
neonatal foreskin. A Real Time PCR was performed on RNA extracts by using 
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primers for p75NTR and sortilin, as described in M&M. p75NTR expression 
levels were used as calibrator. (b) Keratinocyte cultures were trypsinized and 
stained with mouse monoclonal anti-p75NTR and polyclonal anti-sortilin 
antibody. Cells were analyzed by flow cytometry. (c) Normal human 
keratinocytes were separated into three subpopulations on type IV collagen. 
Real Time PCR was performed on RNA extracts of the three populations by 
using primers for sortilin, as described in M&M. KSC were used as calibrator. 
(d) Protein extracts from the three populations were separated on 7% 
polyacrylamide gels and transferred onto nitrocellulose membrane. Membranes 
were immunoblotted with anti-sortilin antibody. (e) Keratinocyte cultures, 
seeded in a 96-well tissue culture plate, were treated with 0.1, 1, 10, 20 ng/ml 
of proNGF. MTT was performed 72 hrs later. (f) Keratinocyte confluent 
cultures, seeded in a 96-wells tissue culture plate, were treated with 10ng/ml 
proNGF or 200nM k252a alone, or in combination. MTT was performed 72 hrs 
later. (g) Confluent keratinocytes, seeded in a tissue culture slide-flask, were 
treated as described above. At 72 hrs cells were fixed and stained in situ with 
TUNEL. Positive cells were counted as described in M&M. (h) HaCaT cells were 
transfected with 2µg of pcDNA3-BimEL (positive control) in combination with 
2µg of pcDNA3-p75NTR and pcDNA3-sortilin. Transfection was controlled by 
Western blotting using anti-sortilin and anti-p75NTR antibody. (i) After 24 hrs, 
cells were treated with 10ng/ml proNGF for 24 hrs. Then, HaCaT cells were 
lysed and caspase activity was assessed using DEVD-AFC substrate. Data 
represent the mean +/- SE of triplicate determinations. 
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Figure 5  NT receptor expression in psoriasis. (a) Cryosections of healthy, 
non lesional and lesional psoriatic skin were acetone-fixed and stained with 
anti-p75NTR antibody. Fast red was used as cromogen. (b) mRNA extracts 
from healthy and psoriatic epidermis were analyzed by Northern blot. DIG-
labeled probes specific for p75NTR or actin were used. (c) Real Time PCR was 
performed on healthy and psoriatic epidermal mRNA, as described in M&M. 
Healthy mRNA was used as calibrator. (d) Protein extracts from healthy, 
lesional and non lesional psoriatic epidermis were separated on 7% 
polyacrylamide gels and transferred onto nitrocellulose membrane. Membranes 
were immunoblotted with anti-p75NTR, anti-sortilin, anti-TrkA, anti-TrkB, anti-
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TrkC and β-actin antibodies. (e) Keratinocyte extracts from healthy, lesional 
and non lesional psoriatic skin were stained with mouse monoclonal anti-
p75NTR antibody. Cells, obtained from three different patients, were analyzed 
by flow cytometry.  
 
 
Figure 6 Reduced levels of p75NTR in TA cells are responsible for 
resistance to apoptosis in psoriatic keratinocytes (a) Normal and 
psoriatic human keratinocytes were obtained from skin biopsies and separated 
into three subpopulations on type IV collagen. Keratinocytes were trypsinized 
and stained with mouse monoclonal anti-p75NTR and analyzed by flow 
cytometry. (b) After 48 hrs, both normal and psoriatic KSC, TA and PM cells 
were stained in situ with PI and analyzed by Confocal Scanning Laser 
Microscopy. Data represent the mean +/- SE of triplicate determinations. (c) 
Keratinocyte cultures obtained from normal and psoriatic biopsies were treated 
with 40µM β-amyloid or 100ng/ml BDNF. MTT was performed 48 hrs later. (d) 
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Keratinocytes were treated as in (c) and subG1 peak was evaluated by flow 
cytometry. Data represent the mean +/- SE from three independent 
experiments. 
 
Figure 7 p75NTR infection restores apoptosis susceptibility in psoriatic 
keratinocytes (a) Psoriatic keratinocytes were double infected with mock or 
p75NTR retroviral vector and infection controlled by Western blotting. (b) 48 
hours after infection, cells were treated with 40µM β-amyloid or 100ng/ml 
BDNF or diluent. MTT was performed 48 hours later. Data represent the mean 
+/- SE of triplicate determinations. (c) Mock and p75NTR infected 
keratinocytes were provided 100ng/ml BDNF or diluent and analyzed by flow 
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cytometry 48 hrs later. Data represent the mean +/- SE of triplicate 
determinations. 
 
